Sequana Medical Secures $21M In Private Placement
Executive Summary
One year on from its IPO on Euronext Brussels, abdominal implant maker Sequana Medical has secured €19m ($21m) in an equity placement. The company said it had been backed by new and existing investors.
You may also be interested in...
European Investor LSP Raises $600M For Life Sciences Fund
LSP says its new fund for medical device and drug development companies will be the biggest fund dedicated to life sciences companies in Europe.
Sequana Medical Launches Belgian IPO
Sequana Medical has launched an IPO on Euronext Brussels a few days after the US FDA granted a breakthrough device designation to Sequana’s alfapump for liver ascites.
Sequana Medical Pumped About NASH's Market Potential
Following a fresh injection of funding, Sequana Medical is gearing up to grow its European business and begin a pivotal US study for alfapump, its implantable, automated pump for the continual removal of ascites. The Belgian company is positioning itself as a key player in the growing liver disease treatment market.